Sanofi-Pasteur Gets $100 Mil. HHS Contract to Make Avian Influenza Vaccine
The number of viable doses will depend upon the outcome of ongoing dosing studies, HHS says.
The number of viable doses will depend upon the outcome of ongoing dosing studies, HHS says.